Outcome differences between debulking surgery and cytoreductive surgery in patients with pseudomyxoma peritonei

European Journal of Surgical Oncology

Volumn 38, Issue 10, 2012, Pages 962-968

  Andreasson H ^a   Graf, W ^a   Nygren, P ^a   Glimelius, B ^a,b   Mahteme, H ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cytoreductive surgery; Debulking surgery; Intraperitoneal chemotherapy; Pseudomyxoma peritonei

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; MITOMYCIN C; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; COMPARATIVE EFFECTIVENESS; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEUTROPENIA; OVERALL SURVIVAL; PATIENT SAFETY; PERFORATION; PERITONEUM PSEUDOMYXOMA; PLEURA EFFUSION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SEPSIS; SWEDEN; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY, NEEDLE; COHORT STUDIES; DATABASES, FACTUAL; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; INFUSIONS, PARENTERAL; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; ODDS RATIO; PERITONEAL NEOPLASMS; PERITONEUM; PSEUDOMYXOMA PERITONEI; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; SWEDEN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84866421485     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2012.07.009     Document Type: Article

References (29)

1. R.M. Smeenk, M.L. van Velthuysen, V.J. Verwaal, and F.A. Zoetmulder Appendiceal neoplasms and pseudomyxoma peritonei: a population based study Eur J Surg Oncol 34 2 2008 196 201
2. P.H. Sugarbaker Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon Ann Surg 219 2 1994 109 111
3. B.M. Ronnett, C.M. Zahn, R.J. Kurman, M.E. Kass, P.H. Sugarbaker, and B.M. Shmookler Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei" Am J Surg Pathol 19 12 1995 1390 1408
4. C. Szych, A. Staebler, D.C. Connolly, R. Wu, K.R. Cho, and B.M. Ronnett Molecular genetic evidence supporting the clonality and appendiceal origin of pseudomyxoma peritonei in women Am J Pathol 154 6 1999 1849 1855
5. J.S. Friedland, J.T. Allardice, and A.P. Wyatt Pseudomyxoma peritonei J R Soc Med 79 8 1986 480 482
6. D.B. Gough, J.H. Donohue, and A.J. Schutt Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach Ann Surg 219 2 1994 112 119
7. T.J. Miner, J. Shia, D.P. Jaques, D.S. Klimstra, M.F. Brennan, and D.G. Coit Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy Ann Surg 241 2 2005 300 308
8. P. Jarvinen, H.J. Jarvinen, and A. Lepisto Survival of patients with pseudomyxoma peritonei treated by serial debulking Colorectal Dis 12 9 2010 868 872
9. P.H. Sugarbaker, K. Kern, and E. Lack Malignant pseudomyxoma peritonei of colonic origin. Natural history and presentation of a curative approach to treatment Dis Colon Rectum 30 10 1987 772 779
10. M. Deraco, D. Baratti, and M.G. Inglese Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei Ann Surg Oncol 11 4 2004 393 398
11. E.M. Murphy, R. Sexton, and B.J. Moran Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm Dis Colon Rectum 50 1 2007 37 42
12. R.M. Smeenk, V.J. Verwaal, N. Antonini, and F.A. Zoetmulder Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Ann Surg 245 1 2007 104 109
13. P.H. Sugarbaker, and D. Chang Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy Ann Surg Oncol 6 8 1999 727 731
14. R.F. Bradley, J.H. Stewart, G.B. Russell, E.A. Levine, and K.R. Geisinger Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review Am J Surg Pathol 30 5 2006 551 559
15. R.L. Harmon, and P.H. Sugarbaker Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer Int Semin Surg Oncol 2 1 2005 3
16. P. Jacquet, and P.H. Sugarbaker Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis Cancer Treat Res 82 1996 359 374
17. C. Wittekind, C.C. Compton, F.L. Greene, and L.H. Sobin TNM residual tumor classification revisited Cancer 94 9 2002 2511 2516
18. P.H. Sugarbaker Peritonectomy procedures Ann Surg 221 1 1995 29 42
19. H. Mahteme, J. Hansson, and A. Berglund Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study Br J Cancer 90 2 2004 403 407
20. W. Graf, J.E. Westlin, L. Pahlman, and B. Glimelius Adjuvant intraperitoneal 5-fluorouracil and intravenous leucovorin after colorectal cancer surgery: a randomized phase II placebo-controlled study Int J Colorectal Dis 9 1 1994 35 39
21. A.A. Sarnaik, J.J. Sussman, S.A. Ahmad, and A.M. Lowy Technology of intraperitoneal chemotherapy administration: a survey of techniques with a review of morbidity and mortality Surg Oncol Clin N Am 12 3 2003 849 863
22. S. van Ruth, R.A. Mathot, R.W. Sparidans, J.H. Beijnen, V.J. Verwaal, and F.A. Zoetmulder Population pharmacokinetics and pharmacodynamics of mitomycin during intraoperative hyperthermic intraperitoneal chemotherapy Clin Pharmacokinet 43 2 2004 131 143
23. D. Elias, M. Bonnay, and J.M. Puizillou Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution Ann Oncol 13 2 2002 267 272
24. H. Mahteme, A. von Heideman, and B. Grundmark Heterogeneous activity of cytotoxic drugs in patient samples of peritoneal carcinomatosis Eur J Surg Oncol 34 5 2008 547 552
25. P.H. Cashin, W. Graf, P. Nygren, and H. Mahteme Intraoperative hyperthermic versus postoperative normothermic intraperitoneal chemotherapy for colonic peritoneal carcinomatosis: a case-control study Ann Oncol 2011
26. P.H. Sugarbaker New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 7 1 2006 69 76
27. H. Mahteme, B. Larsson, A. Sundin, H. Khamis, and W. Graf Uptake of 5-fluorouracil (5-FU) in peritoneal metastases in relation to the route of drug administration and tumour debulking surgery. An autoradiographic study in the rat Eur J Cancer 40 1 2004 142 147
28. A.D. Stephens, R. Alderman, and D. Chang Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique Ann Surg Oncol 6 8 1999 790 796
29. V.J. Verwaal, H. van Tinteren, S.V. Ruth, and F.A. Zoetmulder Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy J Surg Oncol 85 2 2004 61 67